Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells

Molecular Biology Reports

Volumn 39, Issue 1, 2012, Pages 89-95

  Zhang, Ling ^a   Ge, Wei ^a   Hu, Ke ^b   Zhang, Yanyan ^a   Li, Changhu ^a   Xu, Ximing ^a   He, Du ^a   Zhao, Zhenyu ^a   Zhang, Jinzhong ^a   Jie, Fangfang ^a   Chen, Yu ^a   Zheng, Yongfa ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b First Hospital of Jingzhou   (China)

Author keywords

Endostar; HIF 1; Lung cancer; Radioresponse; VEGF

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1; RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; M PHASE CELL CYCLE CHECKPOINT; PROTEIN EXPRESSION; RADIOSENSITIZATION; S PHASE CELL CYCLE CHECKPOINT; TREATMENT RESPONSE;

ADENOCARCINOMA; CELL CYCLE; CELL LINE, TUMOR; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84855201014     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0713-6     Document Type: Article

References (32)

1. HJ Mauceri NN Hanna MA Beckett DH Gorski MJ Staba KA Stellato K Bigelow R Heimann S Gately M Dhanabal GA Soff VP Sukhatme DW Kufe RR Weichselbaum 1998 Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 6690 287 291 9685160 10.1038/28412 1:CAS:528:DyaK1cXkvVKju74%3D (Pubitemid 28335042)
2. C Oehler-Jänne W Jochum O Riesterer A Broggini-Tenzer G Caravatti V Vuong M Pruschy 2007 Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models Mol Cancer Ther 6 9 2496 2504 17876047 10.1158/1535-7163.MCT-07-0253 (Pubitemid 47480415)
3. BB Ma RG Bristow J Kim LL Siu 2003 Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents J Clin Oncol 21 14 2760 2776 12860956 10.1200/JCO.2003.10.044 1:CAS:528:DC%2BD2cXptlCktb0%3D (Pubitemid 46613486)
4. A Abdollahi KE Lipson X Han R Krempien T Trinh KJ Weber P Hahnfeldt L Hlatky J Debus AR Howlett PE Huber 2003 SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro Cancer Res 63 13 3755 3763 12839971 1:CAS:528:DC%2BD3sXltVGqsrk%3D (Pubitemid 36793064)
5. SV Kozin Y Boucher DJ Hicklin P Bohlen RK Jain HD Suit 2001 Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts Cancer Res 61 1 39 44 11196192 1:CAS:528:DC%2BD3MXlsl2msg%3D%3D (Pubitemid 32095696)
6. L Geng E Donnelly G McMahon PC Lin E Sierra-Rivera H Oshinka DE Hallahan 2001 Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 6 2413 2419 11289107 1:CAS:528:DC%2BD3MXisVSlurg%3D (Pubitemid 32685816)
7. CG Lee M Heijn E di-Tomaso G Griffon-Etienne M Ancukiewicz C Koike KR Park N Ferrara RK Jain HD Suit Y Boucher 2000 Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 19 5565 5570 11034104 1:CAS:528:DC%2BD3cXns1ehtL4%3D
8. 2 tension Proc Natl Acad Sci USA 92 12 5510 5514 7539918 10.1073/pnas.92.12.5510 1:CAS:528:DyaK2MXmtFOgs7k%3D
9. RK Bruick SL McKnight 2001 A conserved family of prolyl-4-hydroxylases that modify HIF Science 294 5545 1337 1340 11598268 10.1126/science.1066373 1:CAS:528:DC%2BD3MXotlKmtbo%3D (Pubitemid 33063099)
10. SH Chu DF Feng YB Ma ZA Zhu H Zhang JH Qiu 2009 Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1 Mol Biol Rep 36 7 1967 1975 18979225 10.1007/s11033-008-9406-1 1:CAS:528:DC%2BD1MXptV2ntLs%3D
11. C Yanyan Q Guoxian G Yang W Leting 2008 Mechanism of hypoxia-induced factor 1alpha expression in endothelial cells of the human umbilical vein and its induction of apoptosis Mol Biol Rep 35 3 285 290 17473988 10.1007/s11033-007-9083-5
12. GL Semenza 2009 Regulation of oxygen homeostasis by hypoxia-inducible factor 1 Physiology 24 2 97 106 19364912 10.1152/physiol.00045.2008 1:CAS:528:DC%2BD1MXltFenurk%3D
13. JA Forsythe BH Jiang NV Iyer F Agani SW Leung RD Koos 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol Cell Biol 16 9 4604 4613 8756616 1:CAS:528:DyaK28XltFKjsrc%3D (Pubitemid 26272112)
14. N Ferrara ST Davis 1997 The biology of vascular endothelial growth factor Endocr Rev 18 1 4 25 9034784 10.1210/er.18.1.4 1:CAS:528:DyaK2sXhsFCiu7s%3D (Pubitemid 27076453)
15. A Yuan CJ Yu WJ Chen FY Lin SH Kuo KT Luh PC Yang 2000 Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer Int J Cancer 89 6 475 483 11102890 10.1002/1097-0215(20001120)89:6<475::AID- IJC2>3.0.CO;2-T 1:CAS:528:DC%2BD3cXptVejsrs%3D
16. RM Bremnes C Camps R Sirera 2006 Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood Lung Cancer 51 2 143 158 16360975 10.1016/j.lungcan.2005. 09.005 (Pubitemid 43144358)
17. E Carrillo de Santa Pau FC Arias E Caso Peláez GM Muñoz Molina I Sánchez Hernández I Muguruza Trueba R Moreno Balsalobre S Sacristán López A Gómez Pinillos L del Val Toledo M Obo 2009 Prognostic Significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with non small cell lung cancer Cancer 115 8 1701 1712 19197998 10.1002/cncr.24193
18. Y Teng H Cui M Yang H Song Q Zhang Y Su J Zheng 2009 Protective effect of puerarin on diabetic retinopathy in rats Mol Biol Rep 36 5 1129 1133 18587665 10.1007/s11033-008-9288-2 1:CAS:528:DC%2BD1MXjvFaqurg%3D
19. MS O'Reilly T Boehm Y Shing N Fukai G Vasios WS Lane E Flynn JR Birkhead BR Olsen J Folkman 1997 Endostatin.An endogenous inhibitor of angiogenesis and tumor growth Cell 88 2 277 285 9008168 10.1016/S0092-8674(00)81848-6 (Pubitemid 28015876)
20. O Kisker CM Becker D Prox M Fannon R D'Amato E Flynn WE Fogler BK Sim EN Allred SR Pirie-Shepherd J Folkman 2001 Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model Cancer Res 61 20 7669 7674 11606410 1:CAS:528:DC%2BD3MXnvFSht70%3D (Pubitemid 32995064)
21. SS Yoon H Eto CM Lin H Nakamura TM Pawlik SU Song KK Tanabe 1999 Mouse endostatin inhibits the formation of lung and liver metastases Cancer Res 59 24 6251 6256 10626820 1:CAS:528:DC%2BD3cXktFynsw%3D%3D (Pubitemid 30035650)
22. Y Ling Y Yang N Lu Q You 2007 Endostar, a novel recombinant human endostatin, exerts antiangiogeni blocking VEGF - induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells Biochem Biophys Res Commun 361 1 79 84 17644065 10.1016/j.bbrc.2007.06.155 1:CAS:528:DC%2BD2sXotlWru7k%3D (Pubitemid 47102270)
23. L Hong H Sun X Lv D Yang J Zhang Y Shi 2010 Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human l ung adenocarcinoma cell line (A549) in vitro Mol Biol Rep 37 5 2285 2293 19688273 10.1007/s11033-009-9721-1 1:CAS:528:DC%2BC3cXotVWkurw%3D
24. H Liu T Zhang B Wu J Huang Y Zhou J Zhu 2009 Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells Mol Biol Rep 36 8 2099 2109 19107575 10.1007/s11033-008-9422-1 1:CAS:528:DC%2BD1MXht1yrs7fK
25. W Shi C Teschendorf N Muzyczka DW Siemann 2003 Gene therapy delivery of endostatin enhances the treatment efficacy of radiation Radiother Oncol 66 1 1 9 12559515 10.1016/S0167-8140(02)00280-3 1:CAS:528:DC%2BD3sXmsV2jsg%3D%3D (Pubitemid 36135998)
26. DS Wu CM Wu TH Huang QD Xie 2008 Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model Radiat Environ Biophys 47 2 285 291 18060421 10.1007/s00411-007-0144-x 1:CAS:528:DC%2BD1cXks1Glu7Y%3D
27. X Luo JM Slater DS Gridley 2005 Enhancement of radiation effects by pX-LG-mEndo in lung carcinoma model Int J Radiat Oncol Biol Phys 63 2 553 564 15964154 10.1016/j.ijrobp.2005.01.038 1:CAS:528:DC%2BD2MXhtVWnsLrI (Pubitemid 41317174)
28. QL Wen MB Meng B Yang LL Tu L Jia L Zhou Y Xu Y Lu 2009 Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice Cancer Sci 100 8 1510 1519 19459845 10.1111/j.1349-7006.2009.01193.x 1:CAS:528:DC%2BD1MXhtVWnsLjM
29. H Wu J Deng SY Yu X Wang Y Chen 2010 The Inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms J Huazhong Univ Sci Technol Med Sci 30 1 108 112 20155466 10.1007/s11596-010-0120-6
30. YY Zhen Y Zhao F Liu YD Zhang JJ Wang 2010 The radiosensitization effects of endostar on human lung squamous cancer cells H-520 Cancer Cell Int 24 17 26
31. H Harada S Kizaka-Kondoh G Li S Itasaka K Shibuya M Inoue M Hiraoka 2007 Significance of HIF-1-active cells in angiogenesis and radioresistance Oncogene 26 54 7508 7516 17563752 10.1038/sj.onc.1210556 1:CAS:528:DC%2BD2sXhtlKmurvO (Pubitemid 350207705)
32. N Pore AK Gupta GJ Cerniglia Z Jiang EJ Bernhard SM Evans CJ Koch SM Hahn A Maity 2006 Nelfinavir down-regulates hypoxia-inducible factor 1 alpha and VEGF expression and increases tumor oxygenation: implication for radiotherapy Cancer Res 66 18 9252 9259 16982770 10.1158/0008-5472.CAN-06-1239 1:CAS:528:DC%2BD28Xps1ahsrw%3D (Pubitemid 44521147)